The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Just taken some profit out of BOO, NCYT and SNG and put it in here. Trying hard to get to a holding of 500k shares before the CE-IVD approval RNS and to 1 million ahead of the September update - I am a man with a retirement plan! Fingers crossed. Chin up JAdam, you know Lyn is going to make you rich, it's just a matter of time...
Just think - 17,000 barrels of oil per day - imagine after a week having to find space for 120,000 barrels, after a month 510,000 barrels, I could go on. It's an astonishing amount of oil. £580,000 per day revenue. I gotta get me an oil well.
I can see where you are coming from bakky, it may well have been a buy. I just wish it had been mine! ;)
Good to see that £70k's worth of sells at 08:40 has been taken in our stride. SP 18.7p to buy currently.
Interesting to hear LR say full profitability "in the very near future" - he went further than the statement in the results which said "the near future". I agree that there is going to be a really good newsflow, with September looking like the first numbers on Covid testing, etc. It sounds like the NCYT contract is petering out but I don't mind that as there will be far better margin for YGEN in its own testing business. We can steal a march in France and Germany with the 2-gene test - I anticipate business there will be massive and immediate. The US also offers huge potential. Strange to say but in some ways I won't mind if the SP drifts back to 17p or 16p over August as that will simply represent the buying opportunity of the century. I just don't think it will though and I still see us as being 20p+ this week (or early next week as LR has intimated it might drift into early Aug) on the CE-IVD approval. GLA.
I'll also subscribe to that view Jolly but I do expect us to be 20P+ on CE mark confirmation this week, if not before once we see the presentation today, and to build from there. So, if I am right, there will be a 20% uplift to be had to the SP this week and then over the next few months much, much more. Top up if you can, small band of brothers, and we will share a retirement party like no other.
Well said Racer8, I couldn't have put it better. The personalities at Boohoo are stepping back and letting the professionals run the show, which is great to see.
What an amazing SP reaction to such stunning figures and outlook. There are some games being played out here. If there is a share overhang or some big sellers then once they are cleared this will truly fly. Unbelievable to see that we have another great buying opportunity this morning! After we have seen the presentation today, the Covid testing CE mark this week and a quarter's worth of figures from the NCYT contract and the Clarigene test hopefully very soon, then we will look back and be grateful that we had a last chance to top up risk free. I'm in for another £10k.
Great point about T/O. £500m would be a 5 bagger from here. Definite hold as so much news still to come. Happy days.
I can't wait to see LR's presentation later today. It will be forward looking and may help us to understand just how soon "near term" will be for full profitability and break even. The coming days, weeks and months are going to be huge for YGEN.
Wow wow wow! Editda positive and profitability in the near term. The current FY promises to be fantastic. What's not to like. CE mark for the Covid assay this week so expect another RNS. Keeping a lid on the Covid testing financials until we have actual figures to report - very prudent approach. Well done YGEN!
Nice and steady does it. I expect we will be over 20p ahead of the results on the 28th, possibly higher if news of the CE approval comes in before then. LR however seems keen to wrap as much good news into his presentation as he can so it may not come out ahead of the results. All good here and once the SNG and NCYT hordes smell our scent who knows where we could end up?
Good to make money from NCYT. Take a profit here for now and put it all into YGEN as that is going to be the next BIG gainer in the testing sector - results out next Tuesday but it will be the trading update and the forward looking statements which will make for incredible reading. GLA.
Good to make money from a potentially huge success story with SNG but the risks still remain. Take a profit here for now and put it all into YGEN as that is going to be the next BIG gainer in the testing sector - results out next Tuesday but it will be the trading update and the forward looking statements which will make for incredible reading. GLA.
Here we go. Hold tight.
Perhaps another attempt to keep the SP low? Certainly looks like a sell. The cork will have to pop at some stage though...
The start of the rise. Inexorably upwards until the results on the 28th and then explosively upwards when it becomes clear just how profitable this company is becoming. An NCYT style rise? Maybe not but let's not forget that YGEN is founded on so much more than the more recent COVID testing bonus. I'm starting to get very excited. 320k shares locked away and I'm sensibly looking for an SP of 30p minimum by the end of the month, not so sensibly (but not impossibly) for 50p.
My finger was poised to press buy on Friday but I went with YGEN instead, which supplies NCYT with elements of their COVID testing kit. YGEN SP has not moved to date off the back of this and its other highly-profitable NIPT testing services. It could well explode the way NCYT did. Get in there quick. Good luck with the spike here today - trade it carefully.
Be wary folks - it would be unlike the Sunday Times not to have more dirt to throw around so I am out for the weekend. Hope I'm wrong but the Press in this country just loves to kick those who they think have got above themselves.
Nicely underpins £1.18 as a base on which we can now build, assuming he's more in the know than we are. Just need some contract confirmations and this will fly. Market cap of £38m is peanuts compared to the scale-up potential of the new hygiene related business streams.